ID   P3/NS1/1-Ag4.1
AC   CVCL_2155
SY   P3/NSI/1-AG4-1; P3/NSI/1-Ag4-1; P3/NS1/1-Ag4-1; P3/NS1/1-AG4-1; P3/NS1/Ag4-1; P3 NS1 Ag4/1; P3 NS1 Ag4; P3.NS-1/1.Ag4.1; P3-NS/1-Ag4-1; P3-NS1/1-Ag4-1; P3-NS1/1Ag 4.1; P3/NS-1; NS1/1-Ag4.1; NS1-1 Ag4.1; NS-1-Ag4-1; NS1-Ag4/1; NS1-Ag 4/1; NS1-Ag4; P3-X63-NS/1; P3X63NS1; X63 NS; NS-I/1; NSI/1; NSI/1-Ag4-1; NS-1; NS1; MOPC-21 NS/1; P301; GM03573; GM-3573; GM03573A
DR   BTO; BTO:0001907
DR   CLO; CLO_0008317
DR   CLO; CLO_0008319
DR   CLO; CLO_0008320
DR   CLO; CLO_0017234
DR   CLO; CLO_0050176
DR   CLDB; cl3823
DR   CLDB; cl3824
DR   CLDB; cl3825
DR   CLDB; cl3826
DR   CLDB; cl3827
DR   CLDB; cl3828
DR   ATCC; TIB-18
DR   BCRC; 60036
DR   CCRID; 1101MOU-PUMC000384
DR   CCRID; 1102MOU-NIFDC00041
DR   CCRID; 3101MOUTCM25
DR   CCRID; 4201MOU-CCTCC00011
DR   CCTCC; GDC0011
DR   CLS; 305187
DR   CLS; 400108
DR   Coriell; GM03573
DR   DSMZ; ACC-145
DR   DSMZCellDive; ACC-145
DR   ECACC; 85011427
DR   IZSLER; BS TCL 50
DR   JCRB; JCRB0009
DR   JCRB; JCRB9107
DR   KCLB; 40018
DR   KCLB; 60059
DR   Lonza; 337
DR   NCBI_Iran; C522
DR   RCB; RCB0095
DR   TKG; TKG 0233
DR   Wikidata; Q54937244
RX   CelloPub=CLPUB00447;
RX   PubMed=825377;
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~24 hours (DSMZ=ACC-145).
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C522.
CC   Misspelling: SP3-NS1-Ag-6-1; PubMed=3894247.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse plasma cell myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 33
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=825377; DOI=10.1002/eji.1830060713;
RA   Kohler G.J.F., Milstein C.;
RT   "Derivation of specific antibody-producing tissue culture and tumor
RT   lines by cell fusion.";
RL   Eur. J. Immunol. 6:511-519(1976).
//